B7-H3, a marker related to angiogenesis in hepatocellular carcinoma, promotes contrast-enhanced ultrasound

Read full text Summarise with VIRAT
Authors: HaiYing Tian, Ning Ma, Yuling Chen, bei zhang
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract B7-H3, a member of the B7 family of molecules, is a type I transmembrane glycoprotein that plays a critical role in the development and progression of various cancers. Our study demonstrates that B7-H3 functions as an oncogenic driver in hepatocellular carcinoma (HCC). Specifically, B7-H3 promotes tumor proliferation, migration, invasion, and angiogenesis in HCC. These effects were reversed upon inhibition of B7-H3. We further investigated the underlying mechanism and found that B7-H3 exerts its tumor-promoting functions by activating the NF-κB signaling pathway, thereby promoting the progression of HCC and the level of contrast-enhanced ultrasound. These findings provide a novel theoretical basis for understanding the pathogenesis of hepatocellular carcinoma.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Angiogenesis and VEGF in Cancer Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Research Square
Publication date
18 March 2026
Language
EN
Document type
Preprint